Aditx Therapeutics (ADTX)
(Delayed Data from NSDQ)
$2.41 USD
+0.02 (0.84%)
Updated Apr 29, 2024 03:59 PM ET
After-Market: $2.40 -0.01 (-0.41%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -3.33 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -11.29 |
Next Year | NA |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.22M | 0.22M | 0.64M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -3.33 | -2.69 | -11.29 | NA |
# of Estimates | 1 | 1 | 1 | NA |
Most Recent Consensus | -3.33 | -2.69 | -11.29 | NA |
High Estimate | -3.33 | -2.69 | -11.29 | NA |
Low Estimate | -3.33 | -2.69 | -11.29 | NA |
Year ago EPS | -52.40 | -36.80 | -108.15 | -11.29 |
Year over Year Growth Est. | 93.65% | 92.69% | 89.56% | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 0 | 0 | 0 | NA |
Up Last 60 Days | 0 | 0 | 0 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 0 | 0 | NA |
Down Last 60 Days | 0 | 0 | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -3.33 | -2.69 | -11.29 | NA |
7 Days Ago | -3.33 | -2.69 | -11.29 | NA |
30 Days Ago | -3.33 | -2.69 | -51.28 | -91.97 |
60 Days Ago | -3.33 | -2.69 | -51.28 | -91.97 |
90 Days Ago | -3.33 | -2.69 | -51.28 | -91.97 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -3.33 | -2.69 | -11.29 | NA |
Zacks Consensus Estimate | -3.33 | -2.69 | -11.29 | NA |
Earnings ESP | 0.00% | 0.00% | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -48.77 | -36.80 | -52.40 | NA |
Estimate | NA | -5.99 | -115.60 | -73.20 | NA |
Difference | NA | -42.78 | 78.80 | 20.80 | 18.94 |
Surprise | NA | -714.19% | 68.17% | 28.42% | -205.87% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more